Search

Corvus Pharmaceuticals Inc

Закрыт

12.46 -5.39

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

12.89

Макс.

13.25

Ключевые показатели

By Trading Economics

Доход

-4.3M

-18M

Прибыль на акцию

-0.19

Сотрудники

37

EBITDA

-5.3M

-17M

Рекомендации

By TipRanks

Рекомендации

Активная покупка

Прогноз на 12 месяцев

+128.51% upside

Дивиденды

By Acuity

Следующий отчет о доходах

3 нояб. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

86M

1.2B

Предыдущая цена открытия

17.85

Предыдущая цена закрытия

12.46

Corvus Pharmaceuticals Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

14 сент. 2026 г., 23:56 UTC

Blackstone Inc's shares are higher in after-market hours, reflecting positive movement despite broader U.S. equity weakness. No specific news was identified to explain the rise.

14 сент. 2026 г., 23:56 UTC

RMR Group Inc shares are trading lower in after-market hours amid a broader U.S. equity decline influenced by rising crude oil prices and supply concerns.

14 сент. 2026 г., 23:56 UTC

eHealth Inc. shares are trading higher in after-market hours, recovering from earlier lows despite broader market challenges, including a lower Nasdaq close.

14 сент. 2026 г., 23:56 UTC

Geo Group Inc shares rose in after-market trading, despite broader market declines influenced by rising crude oil prices. No specific news was identified.

14 сент. 2026 г., 23:56 UTC

Extra Space Storage shares are lower in after-market hours, reflecting broader market declines amid rising crude oil prices and ongoing stock performance weakness.

14 сент. 2026 г., 23:56 UTC

CMS Energy shares are higher in after-market trading, reflecting a modest recovery from earlier fluctuations since Monday's close.

14 сент. 2026 г., 23:56 UTC

Shares of Kinder Morgan advanced slightly during after-market hours. This occurred amid a broader market recovery attempt despite lower U.S. equities.

14 сент. 2026 г., 23:56 UTC

Gentex Corp shares are higher in after-market trading, though no specific news was identified. The stock remains below its 20-day moving average.

14 сент. 2026 г., 23:56 UTC

Shares of APA Corp are higher in after-market trading, remaining stable near the upper end of their one-month range amid broader market declines.

14 сент. 2026 г., 23:56 UTC

Rogers Corp shares are higher in after-market trading, though no specific news explains the increase. Broader U.S. equities closed lower amid rising crude oil prices.

14 сент. 2026 г., 23:56 UTC

First Hawaiian Inc shares are higher in after-market trading, despite broader market volatility and major indices closing lower. No specific news was identified for the move.

14 сент. 2026 г., 23:52 UTC

Rush Enterprises shares traded lower after market hours, amid broader market concerns over rising crude oil prices and inflation ahead of the Federal Reserve meeting.

14 сент. 2026 г., 23:52 UTC

Omnicom Group Inc shares are trading lower in after-market hours amid significant weakness in the Advertising sub-sector, remaining below the 20-day moving average.

14 сент. 2026 г., 23:51 UTC

Liberty Energy Inc shares are higher in after-market trading, influenced by rising crude oil prices amid supply concerns from Saudi Arabia's pipeline shutdown.

14 сент. 2026 г., 23:51 UTC

BILL Holdings Inc shares are lower in after-market hours following a pullback from earlier gains. No specific news was identified to explain the decline.

14 сент. 2026 г., 23:51 UTC

News

Rimini Street shares lower in after-market trading despite announcing a partnership with Datacom to support Oracle and SAP software in Australia and New Zealand.

14 сент. 2026 г., 23:51 UTC

National Healthcare Corp shares are higher in after-market trading, following a series of daily gains since Monday's close. No specific news was identified.

14 сент. 2026 г., 23:51 UTC

Correlated Moves
Social Media

SLB NV shares are higher in after-market trading, reflecting strength amid rising crude oil prices and broader energy sector gains, despite mixed sentiment on social media.

14 сент. 2026 г., 23:51 UTC

Devon Energy shares are higher in after-market hours, tracking a broader oil sector trend amid rising crude prices due to supply concerns from Saudi Arabia.

14 сент. 2026 г., 23:51 UTC

China's Industrial Production YoY data set for release on September 15, 2026, with a forecasted growth of 4.8%, amid mixed market sentiment influenced by inflation and geopolitical tensions.

14 сент. 2026 г., 23:51 UTC

China's Retail Sales YoY data for August 2026 expected to rise modestly by 0.8%, amid ongoing concerns over consumer spending and weak performance in key sectors.

14 сент. 2026 г., 23:51 UTC

China's Fixed Asset Investment data release on September 15, 2026, forecasts a continued decline at -0.072%, raising concerns over economic stability amid ongoing property sector struggles.

14 сент. 2026 г., 23:51 UTC

US Initial Jobless Claims Expected at 205,000 Amid Stable Labor Market Sentiment Ahead of September 17 Release.

14 сент. 2026 г., 23:51 UTC

Correlated Moves

Quantumscape Corp shares are lower in after-market hours, breaking a recent trend of higher daily closes amid rising crude oil prices and inflationary pressures.

14 сент. 2026 г., 23:51 UTC

Park Hotels & Resorts shares are lower in after-market hours, continuing a downward trend amid rising crude oil prices and broader market pressures.

14 сент. 2026 г., 23:51 UTC

Baidu Inc. shares are higher in after-market trading, continuing a modest advance since Monday's close, despite remaining below the 20-day moving average.

14 сент. 2026 г., 23:51 UTC

Shares of Synchrony Financial are higher in after-market trading, recovering from a recent low. Broader market factors include rising crude oil prices and inflation concerns.

14 сент. 2026 г., 23:51 UTC

News

Shares of Gartner Inc are lower in after-market hours following unusual weakness, despite the recent launch of its IT Symposium/Xpo conference highlighting key technology trends.

14 сент. 2026 г., 23:51 UTC

Correlated Moves
Social Media

SentinelOne Inc is trading lower in after-market hours amid broader market weakness and fluctuating oil prices ahead of the Federal Reserve's policy meeting.

14 сент. 2026 г., 23:51 UTC

Correlated Moves

Ichor Holdings Ltd shares are higher in after-market trading, supported by a positive trend in the semiconductor sector and gains in Entegris Inc.

Сравнение c конкурентами

Изменение цены

Corvus Pharmaceuticals Inc Прогноз

Целевая цена

By TipRanks

128.51% рост

Прогноз на 12 месяцев

Средняя 29.5 USD  128.51%

Максимум 33 USD

Минимум 27 USD

Основано на мнении 4 аналитиков Wall Street, спрогнозировавших целевые цены для Corvus Pharmaceuticals Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

4 ratings

4

Покупка

0

Удержание

0

Продажа

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immune modulator product candidates to treat solid cancers, T cell lymphomas, autoimmune, allergic, and infectious diseases. Its lead product candidate is soquelitinib (CPI-818), a selective covalent inhibitor of interleukin 2 inducible T cell kinase (ITK), which is in a multi-center Phase 1/1b clinical trial for the treatment of peripheral T cell lymphoma, solid tumors, and atopic dermatitis. The company is also developing ciforadenant (CPI-444), an oral small molecule antagonist of the A2A receptor that is in Phase 2 clinical trial for the treatment of metastatic renal cell cancer; and mupadolimab (CPI-006), a humanized monoclonal antibody, which is in Phase 1b clinical trial for the treatment of non-small cell lung cancer and head and neck cancer. In addition, it is developing CPI-182, an antibody designed to block inflammation and myeloid suppression that is in investigational new drug application-enabling studies, as well as CPI-935, an adenosine A2B receptor antagonist to prevent fibrosis. Corvus Pharmaceuticals, Inc. has a license afreemnt with Monash University to research, develop, and commercialize certain antibodies directed to CXCR2 for the treatment of human diseases; and Vernalis (R&D) Limited to develop, manufacture, and commercialize products containing certain adenosine receptor antagonists, including ciforadenant, as well as strategic collaboration with Angel Pharmaceuticals Co. Ltd. for the development and commercialization of mupadolimab. Corvus Pharmaceuticals, Inc. was incorporated in 2014 and is based in Burlingame, California.
help-icon Live chat